Subtype-specific genomic alterations define new targets for soft-tissue sarcoma therapyJordi Barretina, Samuel Singer, Kinjal Shah et al.|Nature Genetics|2010Cited by 725
Integrative discovery of treatments for high-risk neuroblastomaElin Almstedt, Sven Nelander|Nature Communications|2020Cited by 72
Reconstructing the regulatory programs underlying the phenotypic plasticity of neural cancersIda Larsson, Sven Nelander|Nature Communications|2024Cited by 8